NeRRe Therapeutics Company

NeRRe Therapeutics Ltd. operates as a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists. The company was founded in 2012 and is based in Stevenage, United Kingdom.

Last Funding Type: Series B
Total Funding: $47M
Funding Status: Early Stage Venture
Number Of Exists: Series B
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Technology: Anti-infective Drugs
Investors Number: 7
Founded Date: 2012
Headquarters: Stevenage, Herefordshire, United Kingdom
Investment Stage: N/A
Industry: PharmTech
Investor Type: Company